Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Tonin

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
Journal of Mass Spectrometry : JMS|January 22, 2021
Tri- and dipeptides identification in whey protein and porcine liver protein hydrolysates by fast LC-MS/MS neutral loss screening and de novo sequencingCamila B Poliseli, Angelica P P Tonin, Fernanda C Martinez, et al.
Cancer|June 1, 1997
A descriptive study of BRCA1 testing and reactions to disclosure of test resultsH T Lynch, S J Lemon, C Durham, et al.
JAMA|June 26, 1996
BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomesC Lerman, S Narod, K Schulman, et al.
British Journal of Cancer|March 15, 2012
Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer familiesD J Osher, K De Leeneer, G Michils, et al.
Journal of Neurology|July 14, 2021
Adult-onset mitochondrial movement disorders: a national picture from the Italian NetworkV Montano, D Orsucci, V Carelli, et al.
Functional Neurology|July 6, 2017
European core curriculum in neurorehabilitationGiorgio Sandrini, H Binder, Volker Hömberg, et al.
Molecular Genetics and Metabolism Reports|August 15, 2020
Diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: A single centre experienceA Maguolo, G Rodella, A Dianin, et al.
Nature Genetics|May 1, 1996
Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer familiesC M Phelan, J M Lancaster, P Tonin, et al.
Journal of Neurology|July 11, 2025
Analysis of the Italian cohort of late-onset Pompe disease (LOPD) patients after 10 and 15 years of therapy with alglucosidase alfaT Mongini, G Gadaleta, P Alonge, et al.
Journal of Neurology|November 15, 2011
Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 yearsC Angelini, C Semplicini, S Ravaglia, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Journal of Mass Spectrometry : JMS|January 22, 2021
Tri- and dipeptides identification in whey protein and porcine liver protein hydrolysates by fast LC-MS/MS neutral loss screening and de novo sequencingCamila B Poliseli, Angelica P P Tonin, Fernanda C Martinez, et al.
Cancer|June 1, 1997
A descriptive study of BRCA1 testing and reactions to disclosure of test resultsH T Lynch, S J Lemon, C Durham, et al.
JAMA|June 26, 1996
BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomesC Lerman, S Narod, K Schulman, et al.
British Journal of Cancer|March 15, 2012
Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer familiesD J Osher, K De Leeneer, G Michils, et al.
Journal of Neurology|July 14, 2021
Adult-onset mitochondrial movement disorders: a national picture from the Italian NetworkV Montano, D Orsucci, V Carelli, et al.
Functional Neurology|July 6, 2017
European core curriculum in neurorehabilitationGiorgio Sandrini, H Binder, Volker Hömberg, et al.
Molecular Genetics and Metabolism Reports|August 15, 2020
Diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: A single centre experienceA Maguolo, G Rodella, A Dianin, et al.
Nature Genetics|May 1, 1996
Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer familiesC M Phelan, J M Lancaster, P Tonin, et al.
Journal of Neurology|July 11, 2025
Analysis of the Italian cohort of late-onset Pompe disease (LOPD) patients after 10 and 15 years of therapy with alglucosidase alfaT Mongini, G Gadaleta, P Alonge, et al.
Journal of Neurology|November 15, 2011
Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 yearsC Angelini, C Semplicini, S Ravaglia, et al.
Pageof 11